$AUPH Aurinia Announces PTAB Has Terminated Inter Partes Review

on January 25, 2023 News and Tags: , , , with 0 comments
Time:
11:00 AM
Symbol:
AUPH
Source:
Business Wire
Read more

$AUPH Aurinia Announces PTAB Has Terminated Inter Partes Review

on January 25, 2023 News and Tags: , , , with 0 comments
Time:
11:00 AM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Pharmaceuticals Announces Allowance of a New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis From the United States Patent and Trademark Office

on January 24, 2023 News and Tags: , , , with 0 comments
Time:
2:00 PM
Symbol:
AUPH
Source:
Business Wire
Read more

$AUPH Aurinia Pharmaceuticals Announces Allowance of a New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis From the United States Patent and Trademark Office

on January 24, 2023 News and Tags: , , , with 0 comments
Time:
2:00 PM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2022 Net Revenue Results

on January 6, 2023 News and Tags: , , , with 0 comments
Time:
4:00 AM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2022 Net Revenue Results

on January 6, 2023 News and Tags: , , , with 0 comments
Time:
4:00 AM
Symbol:
AUPH
Source:
Business Wire
Read more

$AUPH Aurinia Pharmaceuticals to Present at Upcoming 41st Annual J.P. Morgan Healthcare Conference

on January 4, 2023 News and Tags: , , , with 0 comments
Time:
2:05 PM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Pharmaceuticals to Present at Upcoming 41st Annual J.P. Morgan Healthcare Conference

on January 4, 2023 News and Tags: , , , with 0 comments
Time:
2:05 PM
Symbol:
AUPH
Source:
Business Wire
Read more

$AUPH Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

on January 3, 2023 News and Tags: , , , with 0 comments
Time:
2:55 PM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Announces LUPKYNIS® (voclosporin) Patent Challenge Settlement Reached With Sun Pharmaceuticals

on January 3, 2023 News and Tags: , , , with 0 comments
Time:
7:12 AM
Symbol:
AUPH
Source:
Business Wire
Read more

$AUPH Aurinia Announces LUPKYNIS® (voclosporin) Patent Challenge Settlement Reached With Sun Pharmaceuticals

on January 3, 2023 News and Tags: , , , with 0 comments
Time:
7:12 AM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

on December 5, 2022 News and Tags: , , , with 0 comments
Time:
2:05 PM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis

on November 30, 2022 News and Tags: , , , with 0 comments
Time:
2:05 PM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results

on November 3, 2022 News and Tags: , , , with 0 comments
Time:
4:00 AM
Symbol:
AUPH
Source:
Business Wire
Read more

$AUPH Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results

on November 3, 2022 News and Tags: , , , with 0 comments
Time:
4:00 AM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Pharmaceuticals to Release Third Quarter 2022 Financial and Operational Results on November 3, 2022

on October 28, 2022 News and Tags: , , , with 0 comments
Time:
3:30 PM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Pharmaceuticals Announces Presentations at American Society of Nephrology (ASN) Kidney Week 2022

on October 27, 2022 News and Tags: , , , with 0 comments
Time:
10:00 AM
Symbol:
AUPH
Source:
Read more

$AUPH Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

on October 3, 2022 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
AUPH
Source:
Business Wire
Read more

$AUPH Aurinia Pharmaceuticals Announces Presentations at American College of Rheumatology (ACR) Convergence 2022

on September 20, 2022 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
AUPH
Source:
Business Wire
Read more

$AUPH Aurinia Announces European Commission Approval of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis

on September 19, 2022 News and Tags: , , , with 0 comments
Time:
11:15 AM
Symbol:
AUPH
Source:
Business Wire
Read more